Pegaptanib Maintained Vision Gains at 2 Years
Pegaptanib sodium injection (Macugen, Eyetech, Inc.)
significantly improved vision in patients with DME and
maintained and expanded vision gains in patients over a
2-year period, according to phase 3 data presented by
Marla B. Sultan, MD, MBA, at the AAO meeting in
Chicago.1
The multicenter, randomized, comparative st...